BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35193889)

  • 1. Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages-prospective study in Rajarata Pregnancy Cohort (RaPCo).
    Koralegedara IS; Warnasekara JN; Dayaratne KG; De Silva FN; Premadasa JK; Agampodi SB
    BMJ Open Gastroenterol; 2022 Feb; 9(1):. PubMed ID: 35193889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy.
    Koralegedara IS; Warnasekara JN; Rathnayake A; Dayaratne KG; Agampodi SB
    BMJ Open Gastroenterol; 2022 Jun; 9(1):. PubMed ID: 35728866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early pregnancy metabolic syndrome and risk for adverse pregnancy outcomes: findings from Rajarata Pregnancy Cohort (RaPCo) in Sri Lanka.
    Jayasinghe IU; Agampodi TC; Dissanayake AK; Agampodi SB
    BMC Pregnancy Childbirth; 2023 Apr; 23(1):231. PubMed ID: 37020187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis.
    Lavrentaki A; Thomas T; Subramanian A; Valsamakis G; Thomas N; Toulis KA; Wang J; Daly B; Saravanan P; Sumilo D; Mastorakos G; Tahrani AA; Nirantharakumar K
    J Diabetes Complications; 2019 Oct; 33(10):107401. PubMed ID: 31326267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus.
    Lee SM; Kwak SH; Koo JN; Oh IH; Kwon JE; Kim BJ; Kim SM; Kim SY; Kim GM; Joo SK; Koo BK; Shin S; Vixay C; Norwitz ER; Park CW; Jun JK; Kim W; Park JS
    Diabetologia; 2019 Feb; 62(2):238-248. PubMed ID: 30470912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of gestational diabetes mellitus in women diagnosed with non-alcoholic fatty liver disease during pregnancy: A systematic review and meta-analysis.
    Chai TYL; Rajaratnam RM; Deng D; George J; Pasupathy D; Cheung NW
    J Diabetes Complications; 2021 Sep; 35(9):107991. PubMed ID: 34219018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of gestational diabetes in a Sri Lankan antenatal clinic.
    Siribaddana SH; Deshabandu R; Rajapakse D; Silva K; Fernando DJ
    Ceylon Med J; 1998 Jun; 43(2):88-91. PubMed ID: 9704548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study.
    De Souza LR; Berger H; Retnakaran R; Vlachou PA; Maguire JL; Nathens AB; Connelly PW; Ray JG
    Am J Gastroenterol; 2016 May; 111(5):665-70. PubMed ID: 26977755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease.
    Ajmera VH; Gunderson EP; VanWagner LB; Lewis CE; Carr JJ; Terrault NA
    Am J Gastroenterol; 2016 May; 111(5):658-64. PubMed ID: 27002796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study.
    Herath RP; Siriwardana SR; Ekanayake CD; Abeysekara V; Kodithuwakku SUA; Herath HP
    PLoS One; 2019; 14(4):e0215326. PubMed ID: 30978266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.
    Li M; Hu M; Yue Z; Zhang Y; Yang H
    PLoS One; 2021; 16(9):e0257391. PubMed ID: 34516586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus.
    Kubihal S; Gupta Y; Shalimar ; Kandasamy D; Goyal A; Kalaivani M; Goyal A; Kedia S; Kachhawa G; Ambekar S; Bhatia D; Garg V; Gupta N; Tandon N
    J Diabetes Investig; 2021 May; 12(5):877-885. PubMed ID: 32961610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods.
    Lee SM; Hwangbo S; Norwitz ER; Koo JN; Oh IH; Choi ES; Jung YM; Kim SM; Kim BJ; Kim SY; Kim GM; Kim W; Joo SK; Shin S; Park CW; Park T; Park JS
    Clin Mol Hepatol; 2022 Jan; 28(1):105-116. PubMed ID: 34649307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of gestational diabetes and fatty liver scores 9 to 16 years after pregnancy.
    Donnelly SR; Hinkle SN; Rawal S; Grunnet LG; Chavarro JE; Vaag A; Wu J; Damm P; Mills JL; Li M; Bjerregaard AA; Thuesen ACB; Gore-Langton RE; Francis EC; Ley SH; Hu FB; Tsai MY; Olsen SF; Zhang C
    J Diabetes; 2019 Nov; 11(11):895-905. PubMed ID: 31001915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previous induced abortion or miscarriage is associated with increased odds for gestational diabetes: a nationwide register-based cohort study in Finland.
    Vaajala M; Liukkonen R; Ponkilainen V; Kekki M; Mattila VM; Kuitunen I
    Acta Diabetol; 2023 Jun; 60(6):845-849. PubMed ID: 36856862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes.
    Forbes S; Taylor-Robinson SD; Patel N; Allan P; Walker BR; Johnston DG
    Diabetologia; 2011 Mar; 54(3):641-7. PubMed ID: 21153530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight.
    Lee SM; Kim BJ; Koo JN; Norwitz ER; Oh IH; Kim SM; Kim SY; Kim GM; Kwak SH; Kim W; Joo SK; Shin S; Vixa C; Park CW; Jun JK; Park JS
    PLoS One; 2019; 14(8):e0221400. PubMed ID: 31449538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes.
    Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
    Eur J Epidemiol; 2023 Aug; 38(8):901-911. PubMed ID: 37253998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease.
    Hagström H; Höijer J; Ludvigsson JF; Bottai M; Ekbom A; Hultcrantz R; Stephansson O; Stokkeland K
    Liver Int; 2016 Feb; 36(2):268-74. PubMed ID: 26114995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Dysfunction-Associated Fatty Liver Disease and Subsequent Development of Adverse Pregnancy Outcomes.
    Lee SM; Jung YM; Choi ES; Kwak SH; Koo JN; Oh IH; Kim BJ; Kim SM; Kim SY; Kim GM; Joo SK; Koo BK; Shin S; Norwitz ER; Park CW; Jun JK; Kim W; Park JS
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2542-2550.e8. PubMed ID: 34798335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.